v3.26.1
Share-based compensation plan - Restricted shares plan (Details)
3 Months Ended
Mar. 31, 2026
BRL (R$)
shares
shares
Mar. 31, 2024
BRL (R$)
Dec. 31, 2025
BRL (R$)
shares
Dec. 31, 2024
BRL (R$)
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Non-current provisions for employee benefits | R$ R$ 360,657,000   R$ 332,322,000  
Restricted share units        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Number of other equity instruments outstanding in share-based payment arrangement 3,035,217   3,076,116  
Shares granted 242,383      
Restricted stock, year one 232,651      
Restricted stock, year two 440,715      
Restricted stock, year three 235,794      
Restricted stock, year four 1,884,420      
Restricted stock, year five 241,637      
Non-current provisions for employee benefits | R$ R$ 78,728,000   R$ 80,742,000 R$ 60,226,000
Increase Provision Share Based Payment | R$ 12,597,000 R$ 45,642,000    
Decrease Provision Share Based Payment | R$ R$ (14,611,000) R$ (25,126,000)    
Grant Year 2023 | Restricted share units        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Fair value on grant date | R$     R$ 50.51  
Number of other equity instruments outstanding in share-based payment arrangement   277,249  
Shares granted 6,033      
Grant Year 2024 | Restricted share units        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Fair value on grant date | R$     R$ 56.09  
Number of other equity instruments outstanding in share-based payment arrangement 2,382,333   2,331,602  
Shares granted 50,731      
Restricted stock, year one 232,651      
Restricted stock, year two 440,715      
Restricted stock, year four 1,708,967      
Grant Year 2025 | Restricted share units        
Disclosure of terms and conditions of share-based payment arrangement [line items]        
Fair value on grant date | R$     R$ 60.47  
Number of other equity instruments outstanding in share-based payment arrangement 477,431   467,265  
Shares granted 10,166      
Restricted stock, year three 235,794      
Restricted stock, year five 241,637